Kirby Corporation
NYSE:KEXMarine Shipping
-$0.22 today
- Market cap
- $6.62B
- Beta
- 0.82
- P/E (TTM)
- 20.9
- EPS (TTM)
- $6.70
Volume 0.42M
Average 0.66M
KEX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Kirby CorporationNYSE: KEX
Research & Development · Q2 FY2026 · quarter ended Jun 2026
Research & development remains negative
Q2 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How KEX compares with its peers on the latest reported figures
- KEX's LTM Jun 2026 research & development of $0 is the highest of the 11 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for KEX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
| LTM Sep 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding KEX) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for KEX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 2.25B | 2.78B | 3.09B | 3.27B | 3.36B |
| Cost of Revenue | 1.87B | 2.26B | 2.39B | 2.44B | 2.48B |
| Gross Profit | 379.98M | 522.37M | 700.06M | 825.2M | 883.42M |
| Gross Margin | 16.9% | 18.8% | 22.6% | 25.3% | 26.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 266.91M | 302.69M | 335.21M | 337.1M | 356.31M |
| Operating Expenses | 638.11M | 329.48M | 364.97M | 426.1M | 391.93M |
| Depreciation & Amortization | 213.72M | 201.44M | 240.12M | 240.32M | 264.13M |
| EBITDA | (34.41M) | 411.01M | 586.26M | 652.21M | 781.87M |
| EBITDA Margin | -1.5% | 14.8% | 19.0% | 20.0% | 23.2% |
| Operating Income | (258.13M) | 192.89M | 335.09M | 399.1M | 491.5M |
| Operating Margin | -11.5% | 6.9% | 10.8% | 12.2% | 14.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 42.47M | 44.59M | 52.01M | 49.13M | 46.33M |
| Other Income / Expenses | (32.47M) | (27.91M) | (40.97M) | (36.33M) | (20.08M) |
| Income Before Tax | (290.6M) | 164.98M | 294.13M | 362.76M | 471.41M |
| Pre-Tax Margin | -12.9% | 5.9% | 9.5% | 11.1% | 14.0% |
| Income Tax Expense | (43.83M) | 42.21M | 71.22M | 75.87M | 116M |
| Net Income | (246.95M) | 122.29M | 222.94M | 286.71M | 354.57M |
| Net Margin | -11.0% | 4.4% | 7.2% | 8.8% | 10.5% |
| EPS (Basic) | (4.11) | 2.04 | 3.74 | 4.95 | 6.37 |
| EPS (Diluted) | (4.11) | 2.03 | 3.72 | 4.91 | 6.33 |
| Weighted Avg Shares | 60.05M | 60.04M | 59.53M | 57.95M | 55.69M |
| Weighted Avg Shares (Diluted) | 60.05M | 60.33M | 59.86M | 58.36M | 56.05M |
Kirby Corporation
NYSE:KEX
Intrinsic Alpha fair value
Locked
Current Price
$127.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.